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OBJECTIVES: To evaluate the impact of pharmacists led intervention programme 
in order to evaluate knowledge, attitude and practice among Hepatitis B patients 
in Pakistan. METHODS: A non clinical randomized control trial was conducted 
whereby Hepatitis-B patients received an educational intervention through 
trained hospital pharmacists who provided them with information about 
Hepatitis-B. Knowledge, attitude and practice were measured by means of self-
administered questionnaire. Descriptive statistics were used to describe  
the demographic characteristics of the patients. Inferential statistics (Chi square 
test, and Mann-Whitney U test) were used for comparison between the groups. 
SPSS 17 was used for data analysis. RESULTS: Three hundred and ninety 
Hepatitis-B patients were randomly assigned to the study (195 patients in  
the control group and in the intervention group). No significant differences  
were observed in either group for mean age, gender, education, occupation, 
income and locality. A significant improvement (p<0.001) in the knowledge, 
attitude and practice (8.48±2.7, 3.87±1.2, 2.37±1.0 to 15.46±2.2, 5.05±1.0, 5.98±1.2) 
was observed in the interventional group. Significant difference (p<0.001) was 
observed after the completion of the intervention programme between the 
control group and in the intervention group. CONCLUSIONS: The pharmacist-led 
intervention caused a significant improvement in knowledge, attitude and 
practice scores of Hepatitis-B patients which will be helpful in the better disease 
management and control. It is recommended that the role of pharmacists in 
patient education must be acknowledged as an integral part of the health care 
system.  
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OBJECTIVES: In recent years, increasing efforts have been dedicated to assess 
the health-related quality of life (HRQL) in people infected with tuberculosis (TB). 
A variety of generic instruments exist to assess quality of life (QoL) in TB 
patients, but a psychometrically sound TB-specific HRQL instrument is lacking. 
The current study aimed to develop a self-reported HRQL measure specific for 
pulmonary TB patients in Iraq. METHODS: The core, general HRQL questionnaire 
is comprised of the Functional Assessment of Cancer Therapy-General (FACT-G) 
items. The FACT-G was selected because of its established psychometrics and 
history in measuring HRQL symptoms in patients with a variety of chronic 
illnesses. A modular approach was followed for the development of Functional 
Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB) questionnaire in 
which a set of items assessing QoL issues not sufficiently covered by the core 
FACT-G items, but considered to be relevant to the target population, were 
added. The development process of an additional concerns subscale of the 
FACIT-TB instrument consisted of several stages, including: 1) Concept 
clarification; 2) Item pool generation; 3) Item reduction; 4) Refinement. RESULTS: 
In addition to the 27 items of the core questionnaire, a set of 20 items referring to 
disease symptoms related to the site of infection (Pulmonary TB); side effects 
and other issues related to treatment; and additional QoL dimensions such as 
fatigue, fear of disease transmission, and economic burden of the illness were 
included in the additional subscale of FACIT-TB. CONCLUSIONS: A rigorous 
method was applied in the development of FACIT-TB to fully understand the 
impact of the illness on QoL of TB patients. However, further linguistic validation 
and psychometric testing should be conducted to ensure conceptual 
equivalence, validity and reliability of the instrument and its relevance among 
Arabic-speaking patients in Iraq.  
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OBJECTIVES: The study evaluated the impact of a health educational 
intervention in improvement of health related quality of life (HRQoL) in Pakistani 
Hepatitis-B patients. METHODS: A non-clinical randomized control trial was 
conducted. Hepatitis B patients received an educational intervention through 
hospital pharmacists who provided them with information about Hepatitis-B 
treatment and management and improvement of HRQoL. Health Related Quality 
of Life was measured by Euroqol (EQ-5D). Descriptive statistics were used to 
describe the demographic characteristics of the patients. Inferential statistics 
(Chi square test, Mann-Whitney U test) were used for inter-group comparison. 
The intra- group comparison was performed by Wilcoxon Rank Sum test. SPSS 
17.0 was used for data analysis. RESULTS: Three hundred and ninety Hepatitis-B 
patients were randomly assigned to the study [195 in each group i.e. control 
group (CG) and the intervention group (IG)]. No significant differences were 
observed in either group for mean age, gender, education, occupation, income 
and locality. There was significant (p<0.001) increase in EQ-5D score from 
0.3498±0.3178 to 0.4739±0.2624 (in post interventional intervention group). The 
results revealed non-statistical significant (p=0.563) between the Interventional 
group (0.4726±0.2522) and control group (0.4745±0.2791) among overall HRQoL 
scores. CONCLUSIONS: The pharmacist-focused intervention led to a significant 
increase in the patient’s health related quality of life. Therefore, the role of 
pharmacists in patient education must be formalized and acknowledged as an 
official part of the health care system.  
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OBJECTIVES: In 2009, voluntary public reporting of hospital health care 
personnel (HCP) vaccination rates began in Illinois. We describe our experience 
over 4 influenza seasons (2009-2013) and examine the impact universal policies 
have had on performance. METHODS: A secure website was used to report 
monthly HCP vaccination rates by each participating hospital. Overall and 
individual hospital performance was publicly reported each month. Statistical 
analysis was performed to compare the HCP vaccination rate before and after 
adoption of a universal policy to compare HCP vaccination rate by policy type for 
each month of the flu season. RESULTS: In the first two seasons, there were 11 
hospitals reporting with an average end of season rate of 76% (2009–2010) and 
81% (2010–2011). In the 2011–2012 season, there were 22 hospitals reporting, 9 of 
which had a new universal policy for HCP influenza vaccination. The average 
2011–2012 end of season rate was 72% for hospitals with a voluntary program 
and 95% for hospitals with a universal policy. HCP were also vaccinated earlier in 
the influenza season when a universal policy was in place, providing greater 
benefit over time. We found that there was a statistically significant difference in 
vaccination rate by type of policy at both the beginning of the influenza season 
and at the end of the influenza season. In the 2012-2013 season, there are 34 
hospitals voluntary participating which reflects a huge increase in terms of 
public reporting of HCP influenza vaccinations; updated results will be 
presented. CONCLUSIONS: A variety of factors may contribute to the rate of 
hospital HCP influenza vaccination. Public reporting of HCP influenza 
vaccination rates may contribute to implementation of universal employee 
vaccination policies. Hospitals with universal policies have higher vaccination 
rates than those with voluntary vaccination programs. Our study has 
demonstrated that implementation of a universal policy contributes to a 
dramatic increase in performance.  
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OBJECTIVES: Community-acquired pneumonia (CAP) is one of the leading causes 
of death due to infection and a primary indication for antibiotic therapy. Multiple 
guidelines exist for recommending initial antibiotic choice for treatment of CAP. 
This study was conducted to evaluate the trends in antibiotic choice for 
treatment of CAP in hospitalized patients (non-ICU) at a tertiary care center, 
Safdarjung Hospital, Delhi, India. METHODS: A retrospective medical record 
review of hospitalized adult patients discharged to home (mean hospital stay 
5.38 days (SD=2.97)) with a diagnosis of CAP in 2007 (n=139) and 2011 (n=142) was 
performed. A standardized form was completed by a trained medical resident. 
RESULTS: The pattern of antibiotic use in 2007 and 2011, respectively, was – 
monotherapy 30.2% versus 21.1%; combination of two antibiotics 61.1% versus 
65.5%; and combination of three antibiotics 8.6% versus 13.3%. 
Amoxicillin+clavulanic acid or ceftriaxone (β-lactam antibiotics) were most 
frequently used as monotherapy in both 2007 (80.9% and 9.5%) and 2011 (56.7% 
and 36.7%). In 2007, combinations of a β-lactam (amoxicillin+clavulanic acid or 
ceftriaxone) and fluoroquinolones (41.2%) or macrolides (31.8%) or 
aminoglycosides (10.6%) were prescribed. In 2011, combinations of 
fluoroquinolones (levofloxacin) and a β-lactam (43.0%) or combinations of β-
lactam and a macrolide (40.9%) were commonly given. Combination of three 
antibiotics usually included a β-lactam combined with macrolides or 
aminoglycosides or fluoroquinolones or metronidazole. Piperacillin+tazobactam 
or ceftazidime+tazobactam were prescribed to 12 patients in 2011 and none in 
2007. Third generation cephalosporins (ceftriaxone, ceftazidime, cefotaxime, 
cefixime) were given to 55 patients in 2011 versus 19 patients in 2007 (test of 
proportion p<0.01). CONCLUSIONS: The study indicates that third generation 
cephalosporins and piperacillin+tazobactam use at the study hospital is 
increasing, whereas amoxicillin+clavulanic acid use is decreasing in non-ICU 
hospitalized patients with CAP. This trend is not in accordance with published 
guidelines and especially concerning in light of emerging antimicrobial 
resistance.  
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OBJECTIVES: The study investigated the local retail drug market to determine 
the prices, availability and affordability of antimalarial medicines to generate 
information for improving access to ACTs METHODS: A cross-sectional survey 
was conducted in retail outlets in Enugu urban SE Nigeria in 2011, based on 
WHO/HAI recommendations. Nine medicines from seven categories of 
antimalarial drugs were surveyed in a sample of 38 retail outlets, selected 
randomly by type and location. Data was collected by structured interviews, in-
depth interviews, and retail audits from both private retail pharmacies and 
patent medicine vendors. RESULTS: The market was highly characterized by a 
wide range of antimalarial medicines, averaging 10 brands per outlet. SPs and 
